March 10, 2023 — The FDA has approved a nasal spray that is expected to provide fast relief from migraines, the pharmaceutical company Pfizer said Friday. The drug zavegepant will be sold under the brand name Zavzpret and should be available in pharmacies by July 2023, the company said in a news release. The cost …
Continue reading “FDA Approves Fast-Acting Nasal Spray for Migraines, Pfizer Says”